Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus.
about
Healthcare quality in systemic lupus erythematosus: using Donabedian’s conceptual framework to understand what we knowThe impact of rural residency on the expression and outcome of systemic lupus erythematosus: data from a multiethnic Latin American cohort.Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United StatesClinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri LankaInfluence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohortAttribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus RegistryIncidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus RegistryEpidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis.European genetic ancestry is associated with a decreased risk of lupus nephritisInsights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.Systemic lupus erythematosus observations of travel burden: A qualitative inquiry.
P2860
Q24613829-657D1608-FDEF-40C8-BC46-3876ED5CD9B0Q30560762-2D4DDD66-4CE7-4312-8DBB-47F89BCE319FQ33945242-E77EA3DE-B480-45A4-95FA-3FAFD5434CC7Q36266807-C8FE5CE6-D245-4C16-9B58-18809A63B0F3Q36313012-B607985F-FF81-497E-8EEC-F177737C0C6FQ36517240-491E13D9-3529-4838-BA71-AE339647907AQ36540787-61C6B60F-7C92-4128-94DA-2AC3A19735E4Q37069392-27500FBC-680C-4992-AD0E-7708F489F25CQ37352584-756160F9-C136-4A08-8CAF-4EBF6588CA34Q37398821-9730929A-080C-4B6A-82DF-9A060232FBCFQ38877052-CE25A03A-2CCF-4CD0-A815-E466D16326C9Q40553708-999D596D-8C25-49BD-A1BA-5F4189B86787Q40735037-F6970EF1-866C-4B01-8A78-2854BB48E579
P2860
Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Access to care and the inciden ...... systemic lupus erythematosus.
@ast
Access to care and the inciden ...... systemic lupus erythematosus.
@en
Access to care and the inciden ...... systemic lupus erythematosus.
@nl
type
label
Access to care and the inciden ...... systemic lupus erythematosus.
@ast
Access to care and the inciden ...... systemic lupus erythematosus.
@en
Access to care and the inciden ...... systemic lupus erythematosus.
@nl
prefLabel
Access to care and the inciden ...... systemic lupus erythematosus.
@ast
Access to care and the inciden ...... systemic lupus erythematosus.
@en
Access to care and the inciden ...... systemic lupus erythematosus.
@nl
P2860
P356
P1476
Access to care and the inciden ...... systemic lupus erythematosus.
@en
P2093
Michael M Ward
P2860
P304
P356
10.3899/JRHEUM.091199
P407
P577
2010-04-15T00:00:00Z